Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of an LC-MS/MS-based method for quantification and pharmacokinetics study on SCID mice of a dehydroabietylamine-adamantylamine conjugate, a promising inhibitor of the DNA repair enzyme.
Okhina AA, Rogachev AD, Kovaleva KS, Yarovaya OI, Khotskina AS, Zavyalov EL, Vatsadze SZ, Pokrovsky AG, Salakhutdinov NF. Okhina AA, et al. Among authors: vatsadze sz. J Pharm Biomed Anal. 2023 Sep 20;234:115507. doi: 10.1016/j.jpba.2023.115507. Epub 2023 Jun 7. J Pharm Biomed Anal. 2023. PMID: 37331915
Corrigendum: The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper.
Belenkaya SV, Merkuleva IA, Yarovaya OI, Chirkova VY, Sharlaeva EA, Shanshin DV, Volosnikova EA, Vatsadze SZ, Khvostov MV, Salakhutdinov NF, Shcherbakov D. Belenkaya SV, et al. Among authors: vatsadze sz. Front Bioeng Biotechnol. 2023 Nov 6;11:1294266. doi: 10.3389/fbioe.2023.1294266. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 38026885 Free PMC article.
The main protease 3CLpro of the SARS-CoV-2 virus: how to turn an enemy into a helper.
Belenkaya SV, Merkuleva IA, Yarovaya OI, Chirkova VY, Sharlaeva EA, Shanshin DV, Volosnikova EA, Vatsadze SZ, Khvostov MV, Salakhutdinov NF, Shcherbakov DN. Belenkaya SV, et al. Among authors: vatsadze sz. Front Bioeng Biotechnol. 2023 Jun 29;11:1187761. doi: 10.3389/fbioe.2023.1187761. eCollection 2023. Front Bioeng Biotechnol. 2023. PMID: 37456729 Free PMC article.
Supramolecular Organogels Based on N-Benzyl, N'-Acylbispidinols.
Medved'ko AV, Dalinger AI, Nuriev VN, Semashko VS, Filatov AV, Ezhov AA, Churakov AV, Howard JAK, Shiryaev AA, Baranchikov AE, Ivanov VK, Vatsadze SZ. Medved'ko AV, et al. Among authors: vatsadze sz. Nanomaterials (Basel). 2019 Jan 11;9(1):89. doi: 10.3390/nano9010089. Nanomaterials (Basel). 2019. PMID: 30641896 Free PMC article.
Design and Evaluation of Bispidine-Based SARS-CoV-2 Main Protease Inhibitors.
Shcherbakov D, Baev D, Kalinin M, Dalinger A, Chirkova V, Belenkaya S, Khvostov A, Krut'ko D, Medved'ko A, Volosnikova E, Sharlaeva E, Shanshin D, Tolstikova T, Yarovaya O, Maksyutov R, Salakhutdinov N, Vatsadze S. Shcherbakov D, et al. ACS Med Chem Lett. 2021 Sep 29;13(1):140-147. doi: 10.1021/acsmedchemlett.1c00299. eCollection 2022 Jan 13. ACS Med Chem Lett. 2021. PMID: 35043075 Free PMC article.
Bispidine Platform as a Tool for Studying Amide Configuration Stability.
Krut'ko DP, Medved'ko AV, Lyssenko KA, Churakov AV, Dalinger AI, Kalinin MA, Gudovannyy AO, Ponomarev KY, Suslov EV, Vatsadze SZ. Krut'ko DP, et al. Among authors: vatsadze sz. Molecules. 2022 Jan 10;27(2):430. doi: 10.3390/molecules27020430. Molecules. 2022. PMID: 35056748 Free PMC article.
26 results